You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Abbott announced today that its High Sensitive Troponin-I blood test has been CE marked.
The test is now available for use on the company's Architect system for cardiac risk assessment in countries that recognize the designation.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.